K-numberK241127
Device nameINNO SLA Mini Plus® Implant System
ApplicantCowellmedi Co., Ltd.
Product codeDZE
Device classClass II
Decision dateDec 27, 2024
DecisionSubstantially Equivalent
Regulation872.3640
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The INNO SLA Mini Plus® Implant System is a one-piece endosseous dental implant made of commercially pure titanium with SLA surface treatment. It has two types: a Cemented Type for temporary support of missing maxillary lateral or mandibular central/lateral incisors during healing of permanent implants, and a Ball Type for temporary overdenture support (max 180 days), both indicated for immediate loading when primary stability is achieved.

Technological characteristics

The device differs from predicate devices primarily in surface treatment (SLA vs. RBM), diameter range (2.5/3.0 mm vs. 2.0–3.5 mm), and length options (10.0/12.0/14.0 mm vs. broader ranges). Companion components include protection caps (4.05 mm diameter, 6.8 mm length, POM material) and ball attachments with nylon prosthetic retention (3.4 mm abutment diameter, Ti-6Al-4V ELI abutment).

Test standards cited

ISO 17665-1 and ISO 17665-2 (sterilization validation); ANSI/AAMI ST72:2011 (bacterial endotoxins testing via LAL gel-clot technique); ASTM F2052, F2213, F2182, and F2119 (MRI safety testing for magnetic displacement force, torque, RF heating, and image artifact).

Substantial equivalence argument

The Cemented Type shares identical intended use, design concept, and principle of operation with the S-Mini Implant System (K112540) predicate, with size ranges that fall within predicate scope. The Ball Type similarly matches the S-Mini predicate for overdenture support. Although surface treatment differs (SLA vs. RBM), biocompatibility and chemical analysis testing demonstrated the difference does not raise substantial equivalence questions. Protection caps and ball attachments have the same intended use, raw materials, and technical characteristics as predicate components, supported by biocompatibility testing.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →